Literature DB >> 16617919

The neurobiology of the human febrile response.

Chuck Biddle1.   

Abstract

Fever is a normal adaptation in response to a pyrogenic stimulus resulting in the generation of cytokines and prostaglandins. Fever differs from hyperpyrexia and hyperthermia associated with hot environs and pharmacological triggers. Typically, pyrogens are infectious organisms or their direct products (toxins). The body produces a wide array of pyrogenic cytokines such as interleukins (IL-1, IL-6), interferon, and tumor necrosis factor. Tissue trauma can trigger the febrile response, as can infectious organisms, certain medications, and blood products. The circumventricular organ system (CVOS) is neuronal tissues lying outside the blood-brain barrier that has a key role in initiating the communication sequence responsible for the synthesis of febrile prostaglandins. When pyrogenic cytokines are detected by the CVOS, prostaglandin synthesis, especially cyclooxygenase-dependent prostaglandin E2, is induced, activating the febrile response. Once the appropriate signal is received by the hypothalamus, autonomic, endocrine, and behavioral processes are activated until the hypothalamic set-point is reset downward as a consequence of a reduction in pyrogen content or antipyretic therapy, with subsequent heat loss. There is little evidence that fever facilitates recovery from disease or assists the immune system in mounting a response. Antipyretics are used commonly to decrease the distressing manifestations associated with fever.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617919

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  16 in total

1.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

2.  Fever: to treat or not to treat?

Authors:  Miguel Glatstein; Dennis Scolnik
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 2.764

Review 3.  Fever after maxillofacial surgery: a critical review.

Authors:  Amelia Christabel; Ravi Sharma; R Manikandhan; P Anantanarayanan; N Elavazhagan; Pramod Subash
Journal:  J Maxillofac Oral Surg       Date:  2014-01-14

4.  Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis.

Authors:  Troy A Roepke; Martha A Bosch; Elizabeth A Rick; Benjamin Lee; Edward J Wagner; Dana Seidlova-Wuttke; Wolfgang Wuttke; Thomas S Scanlan; Oline K Rønnekleiv; Martin J Kelly
Journal:  Endocrinology       Date:  2010-08-04       Impact factor: 4.736

5.  Fatty acids rehabilitated long-term neurodegenerative: like symptoms in olfactory bulbectomized rats.

Authors:  Shlomo Yehuda; Sharon Rabinovitz
Journal:  J Neural Transm (Vienna)       Date:  2014-10-08       Impact factor: 3.575

6.  High fever following postpartum administration of sublingual misoprostol.

Authors:  J Durocher; J Bynum; W León; G Barrera; B Winikoff
Journal:  BJOG       Date:  2010-04-19       Impact factor: 6.531

7.  No association between ApoE polymorphism and febrile seizures.

Authors:  Pierre Lavenex; Pamela Banta Lavenex; François Cachat; Mario Gehri; Typhaine Juvet
Journal:  Neurol Sci       Date:  2015-08-02       Impact factor: 3.307

8.  Does the CDC Definition of Fever Accurately Predict Inflammation and Infection in Persons With SCI?

Authors:  Michelle Trbovich; Carol Li; Shuko Lee
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

9.  Inhibition of prostaglandin synthesis reduces the induction of MyoD expression in rat soleus muscle.

Authors:  M Monda; C Vicidomini; An Viggiano; S Sampaolo; G Di Iorio; Al Viggiano; E Viggiano; B De Luca
Journal:  J Muscle Res Cell Motil       Date:  2009-06-13       Impact factor: 2.698

10.  ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.

Authors:  Angela Lanciotti; Maria Stefania Brignone; Enrico Bertini; Tamara C Petrucci; Francesca Aloisi; Elena Ambrosini
Journal:  Transl Neurosci       Date:  2013-06-01       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.